Skip to main content
. 2015 Mar 23;17(3):317–328. doi: 10.1016/j.neo.2015.02.003

Figure 1.

Figure 1

Deptor expression is decreased in aggressive breast cancers. (A) Oncomine data examining Deptor expression in normal and malignant cancer tissues using Richardson Breast 2 data set. (B) Deptor expression is dramatically reduced in metastatic 4T1 cell lines as compared with their nonmetastatic 67NR and 4T07 counterparts. (C) Deptor expression is dramatically reduced in malignant MCF10Ca1h and MCF10Ca1a cells as compared to their weakly tumorigenic MCF10aT1K counterpart. (D) Deptor expression is noticeably absent in basal-like/TNBC MDA-MB-231 cells as compared to luminal MCF7 cells. Immunoblots in B to D are representative of three independent experiments.